![](https://webarchive.library.unt.edu/web/20090131134135im_/http://cancertrials.nci.nih.gov/images/spacer.gif) |
|
Anal Cancer Trial Results
1. Cisplatin No Better than Standard Therapy for Anal Canal Cancer (Posted: 04/30/2008) - Replacing mitomycin with cisplatin in chemoradiotherapy for cancer of the anal canal failed to improve either disease-free or overall survival and resulted in more patients needing colostomies, according to a study in the April 23, 2008, Journal of the American Medical Association.
|
|
![](https://webarchive.library.unt.edu/web/20090131134135im_/http://cancertrials.nci.nih.gov/images/spacer.gif) |